Media coverage about Cross Country Healthcare (NASDAQ:CCRN) has been trending somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cross Country Healthcare earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave news articles about the business services provider an impact score of 45.7756117368261 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Cross Country Healthcare (NASDAQ:CCRN) traded up $0.03 during midday trading on Friday, hitting $13.11. 63,700 shares of the company’s stock were exchanged, compared to its average volume of 168,459. The stock has a market capitalization of $477.17, a PE ratio of 20.44, a P/E/G ratio of 1.73 and a beta of 0.68. Cross Country Healthcare has a fifty-two week low of $11.07 and a fifty-two week high of $16.38. The company has a current ratio of 2.14, a quick ratio of 2.14 and a debt-to-equity ratio of 0.46.
A number of research firms recently commented on CCRN. Zacks Investment Research raised shares of Cross Country Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, January 9th. BidaskClub raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 3rd. BMO Capital Markets decreased their target price on shares of Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating for the company in a research report on Monday, November 6th. Credit Suisse Group began coverage on shares of Cross Country Healthcare in a research report on Tuesday, November 7th. They set a “neutral” rating and a $13.00 target price for the company. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $18.00 target price on shares of Cross Country Healthcare in a research report on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $15.00.
In other Cross Country Healthcare news, General Counsel Susan E. Ball sold 25,000 shares of the firm’s stock in a transaction on Friday, December 8th. The shares were sold at an average price of $14.19, for a total value of $354,750.00. Following the completion of the transaction, the general counsel now owns 126,921 shares of the company’s stock, valued at $1,801,008.99. The transaction was disclosed in a filing with the SEC, which is available at this link. Company insiders own 3.90% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://ledgergazette.com/2018/02/16/cross-country-healthcare-ccrn-given-daily-coverage-optimism-rating-of-0-23.html.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.